FDA.reportPublic FDA data

testosterone undecanoate 200 MG Oral Capsule [Kyzatrex]

RxCUI
2609611
RxNorm name
testosterone undecanoate 200 MG Oral Capsule [Kyzatrex]
Display name
testosterone undecanoate 200 MG Oral Capsule [Kyzatrex]
Full name
testosterone undecanoate 200 MG Oral Capsule [Kyzatrex]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7f7167a7-2a25-47e2-acf5-33f499fce971KYZATREX 200 MG Oral Capsule [PSN] · testosterone undecanoate 200 MG Oral Capsule [Kyzatrex] [SBD] · Kyzatrex 200 MG Oral Capsule [SY]322These highlights do not include all the information needed to use KYZATREX® safely and effectively. See full prescribing information for KYZATREX®. KYZATREX® (testosterone undecanoate) capsules, for oral use, CIII Initial U.S. approval: 195320251015